Hancock Whitney’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-31,494
| Closed | -$977K | – | 622 |
|
|
2022
Q2 | $977K | Sell |
31,494
-535
| -2% | -$16.6K | 0.04% | 315 |
|
|
2022
Q1 | $1.32M | Buy |
32,029
+22,687
| +243% | +$931K | 0.04% | 303 |
|
|
2021
Q4 | $407K | Sell |
9,342
-858
| -8% | -$37.4K | 0.01% | 521 |
|
|
2021
Q3 | $511K | Sell |
10,200
-13,252
| -57% | -$664K | 0.02% | 469 |
|
|
2021
Q2 | $1.48M | Sell |
23,452
-8,117
| -26% | -$512K | 0.05% | 341 |
|
|
2021
Q1 | $2.93M | Buy |
31,569
+10,093
| +47% | +$938K | 0.1% | 185 |
|
|
2020
Q4 | $1.92M | Buy |
21,476
+9,155
| +74% | +$820K | 0.06% | 275 |
|
|
2020
Q3 | $1.27M | Sell |
12,321
-24
| -0.2% | -$2.48K | 0.05% | 330 |
|
|
2020
Q2 | $976K | Buy |
+12,345
| New | +$976K | 0.04% | 369 |
|
|
2016
Q3 | – | Sell |
-24,130
| Closed | -$679K | – | 555 |
|
|
2016
Q2 | $679K | Buy |
24,130
+130
| +0.5% | +$3.66K | 0.03% | 406 |
|
|
2016
Q1 | $872 | Hold |
24,000
| – | – | 0.04% | 334 |
|
|
2015
Q4 | $960K | Buy |
24,000
+1,000
| +4% | +$40K | 0.04% | 301 |
|
|
2015
Q3 | $655K | Buy |
+23,000
| New | +$655K | 0.03% | 388 |
|